サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1807078

近赤外イメージングの世界市場：製品別、手術別、用途別、エンドユーザー別、地域別 - 予測（～2030年）

Near-infrared Imaging Market by Product (Imaging System, Probe, Dye), Procedure, Application, End User & Region - Global Forecast to 2030

出版日
ページ情報
英文 289 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
近赤外イメージングの世界市場：製品別、手術別、用途別、エンドユーザー別、地域別 - 予測（～2030年）
出版日: 2025年08月30日
発行: MarketsandMarkets
ページ情報: 英文 289 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の近赤外イメージングの市場規模は、2025年の12億8,000万米ドルから2030年までに19億9,000万米ドルに達すると予測され、予測期間にCAGRで9.3%の成長が見込まれます。

調査範囲
調査対象年 2024年～2030年
基準年 2024年
予測期間 2025年～2030年
単位 10億米ドル
セグメント 製品、手術、用途、エンドユーザー、地域
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

手術ガイダンスや分子イメージングへのハイブリッド近赤外イメージングモダリティの採用や、近赤外イメージングモダリティの技術の進歩、世界的な手術件数の増加が、予測年間の市場成長を押し上げると予測される主因です。さらに、従来の可視化手法に対する近赤外イメージングの優位性も、近赤外イメージングの需要の増加に大きく寄与する要因となっています。

Near-infrared Imaging Market-IMG1

手術別では、消化器手術セグメントが2024年に最大の市場シェアを占めました。

大腸がん、クローン病、潰瘍性大腸炎、胃腫瘍などの消化器疾患の罹患率の上昇が外科的介入の必要性を著しく高めており、調査期間のカラム需要を促進すると予測されます。

用途別では、臨床イメージングセグメントが2024年に最大の市場シェアを占めました。

このセグメントの成長は、この技術が提供する利点と臨床応用に向けた蛍光イメージングの進歩による、このイメージングモダリティの採用の増加によるものと考えられます。

アジア太平洋が予測期間にもっとも高い成長率を記録する見込みです。

多数の患者の存在、高齢者の増加、がんや心血管疾患の巨大な人口基盤が、予測期間のこの地域の成長を促進します。

当レポートでは、世界の近赤外イメージング市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要な知見

  • 近赤外イメージング市場の概要
  • 欧州の近赤外イメージング市場：製品別、国別（2024年）
  • 近赤外イメージング市場：地理的成長機会
  • 近赤外イメージング市場：地域の構成（2023年～2030年）

第5章 市場の概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 規制分析
    • 規制機関、政府機関、その他の組織
    • 規制情勢
  • 償還分析
  • バリューチェーン分析
    • 研究開発
    • 調達と製品開発
    • マーケティング、販売、流通
  • サプライチェーン分析
    • 著名企業
    • 中小企業
    • エンドユーザー
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 主なステークホルダーと購入基準
  • 貿易分析
    • 近赤外イメージング製品の輸入データ（HSコード902750）
    • 近赤外イメージング製品の輸出データ（HSコード902750）
  • 特許分析
  • 価格設定の分析
    • 近赤外イメージング製品の平均販売価格：タイプ別
    • 近赤外イメージング製品の平均販売価格：主要企業別
    • 近赤外イメージング製品の平均販売価格：地域別
  • 技術分析
    • 主要技術
    • 補完技術
    • 隣接技術
  • ケーススタディ分析
    • 技術的な課題
    • 契約製造への依存度の低下
  • 主な会議とイベント（2025年～2026年）
  • カスタマービジネスに影響を与える動向/混乱
  • 投資と資金調達のシナリオ
  • アンメットニーズの分析
  • 近赤外イメージング市場における生成AIの影響
  • 近赤外イメージング市場に対する2025年の米国関税の影響
    • 主な関税率
    • 価格の影響の分析
    • 国/地域に対する価格の影響
    • 国/地域に対する影響
    • 最終用途産業に対する影響

第6章 近赤外イメージング市場：製品別

  • イントロダクション
  • デバイス
    • 蛍光イメージングシステム
    • 蛍光・生物発光イメージングシステム
  • 薬品/プローブ
    • インドシアニングリーン
    • その他の試薬
  • 染料
    • 有機染料
    • ナノ粒子染料

第7章 近赤外イメージング市場：手術別

  • イントロダクション
  • がん手術
    • 脳腫瘍手術
    • その他のがん手術
  • 消化器手術
    • 大腸手術
    • その他の消化器手術
  • 心血管手術
  • 形成外科/再建手術
  • 産婦人科手術
  • その他の手術

第8章 近赤外イメージング市場：用途別

  • イントロダクション
  • 前臨床イメージング
  • 臨床イメージング
  • 医用画像

第9章 近赤外イメージング市場：エンドユーザー別

  • イントロダクション
  • 病院・外科クリニック
  • 製薬・バイオテクノロジー企業
  • 研究所・学術機関
  • その他のエンドユーザー

第10章 近赤外イメージング市場：地域別

  • イントロダクション
  • 北米
    • 北米のマクロ経済の見通し
    • 米国
    • カナダ
  • 欧州
    • 欧州のマクロ経済の見通し
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • アジア太平洋のマクロ経済の見通し
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ラテンアメリカのマクロ経済の見通し
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 中東・アフリカ
    • 中東・アフリカのマクロ経済の見通し
    • GCC諸国
    • その他の中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要参入企業の戦略/強み
  • 収益分析（2020年～2024年）
  • 市場シェア分析（2024年）
  • 企業の評価マトリクス：主要企業（2024年）
  • 企業の評価マトリクス：スタートアップ/中小企業（2024年）
  • 企業の評価と財務指標
  • ブランド/製品の比較
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • STRYKER
    • CARL ZEISS MEDITEC AG
    • PERKINELMER, INC.
    • OLYMPUS CORPORATION
    • LEICA MICROSYSTEMS
    • KARL STORZ SE & CO. KG
    • SHIMADZU CORPORATION
    • LI-COR BIOTECH, LLC
    • HAMAMATSU PHOTONICS K.K.
    • QUEST MEDICAL IMAGING B.V.
    • MERCK KGAA (SIGMA-ALDRICH)
    • MIZUHO MEDICAL CO., LTD.
    • TELEDYNE PRINCETON INSTRUMENTS
    • THERMO FISHER SCIENTIFIC INC.
    • FLUOPTICS SAS (PART OF GETINGE)
    • MEDTRONIC
    • CAYMAN CHEMICAL
    • MP BIOMEDICALS
    • CRYSTA-LYN CHEMICAL COMPANY
    • GOWERLABS LTD.
  • その他の企業
    • NIRX MEDICAL TECHNOLOGIES, LLC
    • EXOSENS (XENICS NV)
    • BIOTIUM
    • TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.
    • AAT BIOQUEST, INC.
    • OXFORD INSTRUMENTS
    • MOTHERSON
    • PHOTON ETC
    • SOTERIX MEDICAL INC.
    • KERNEL

第13章 付録

図表

List of Tables

  • TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS
  • TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 3 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 US: APPROVED IMAGING DEVICES BY FDA
  • TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 13 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (2025)
  • TABLE 14 NEAR-INFRARED IMAGING MARKET: ROLE IN ECOSYSTEM
  • TABLE 15 NEAR-INFRARED IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEAR-INFRARED IMAGING PRODUCTS
  • TABLE 17 KEY BUYING CRITERIA FOR NEAR-INFRARED IMAGING PRODUCTS
  • TABLE 18 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750), BY COUNTRY, 2020-2024 (USD)
  • TABLE 19 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750), BY COUNTRY, 2020-2024 (USD)
  • TABLE 20 AVERAGE SELLING PRICE OF TOP NIR PRODUCTS, BY KEY PLAYER, 2024 (USD)
  • TABLE 21 AVERAGE SELLING PRICE TREND OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION, 2022-2024
  • TABLE 22 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
  • TABLE 23 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES
  • TABLE 24 NEAR-INFRARED IMAGING MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
  • TABLE 25 NEAR-INFRARED IMAGING MARKET: CURRENT UNMET NEEDS
  • TABLE 26 US-ADJUSTED RECIPROCAL TARIFF RATES (AS OF AUGUST, 2025)
  • TABLE 27 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 28 NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 29 NEAR-INFRARED IMAGING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 NEAR-INFRARED IMAGING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 31 NEAR-INFRARED IMAGING DEVICES MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 32 NEAR-INFRARED IMAGING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 33 NEAR-INFRARED IMAGING DEVICES MARKET FOR FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 NEAR-INFRARED IMAGING DEVICES MARKET FOR FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 36 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 38 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 39 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 40 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET FOR INDOCYANINE GREEN, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET FOR OTHER REAGENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 43 NEAR-INFRARED IMAGING DYES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 NEAR-INFRARED IMAGING DYES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 45 NEAR-INFRARED IMAGING DYES MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 46 NEAR-INFRARED IMAGING DYES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 47 NEAR-INFRARED IMAGING DYES MARKET FOR ORGANIC DYES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 48 NEAR-INFRARED IMAGING DYES MARKET FOR NANOPARTICLE DYES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 50 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 51 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 NEAR-INFRARED IMAGING MARKET FOR BRAIN CANCER/TUMOR SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 NEAR-INFRARED IMAGING MARKET FOR OTHER CANCER SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 55 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 NEAR-INFRARED IMAGING MARKET FOR COLORECTAL SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 NEAR-INFRARED IMAGING MARKET FOR OTHER GASTROINTESTINAL SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 63 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 65 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 67 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 70 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 71 NEAR-INFRARED IMAGING MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 72 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 73 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 75 NORTH AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 81 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 82 US: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 US: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 US: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 85 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 86 CANADA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 87 CANADA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 CANADA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: KEY MACROINDICATORS
  • TABLE 90 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 92 EUROPE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 93 EUROPE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 EUROPE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 97 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 98 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 99 GERMANY: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 GERMANY: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 GERMANY: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 103 FRANCE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 FRANCE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 FRANCE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 107 UK: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UK: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 109 UK: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 UK: NUMBER OF FLUOROSCOPY IMAGING ACTIVITIES, 2012-2024
  • TABLE 111 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 112 ITALY: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 ITALY: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 ITALY: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 116 SPAIN: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 SPAIN: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 SPAIN: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 124 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 132 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 133 CHINA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 CHINA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 CHINA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 137 JAPAN: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 JAPAN: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 JAPAN: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 141 INDIA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 INDIA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 INDIA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 145 AUSTRALIA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 AUSTRALIA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 AUSTRALIA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 149 SOUTH KOREA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 150 SOUTH KOREA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 SOUTH KOREA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 153 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 157 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 158 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 159 LATIN AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 LATIN AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 LATIN AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 163 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 164 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 165 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 166 BRAZIL: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 BRAZIL: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 BRAZIL: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 170 MEXICO: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 MEXICO: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 MEXICO: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 174 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 178 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 185 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 186 GCC COUNTRIES: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 187 GCC COUNTRIES: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 GCC COUNTRIES: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 GCC COUNTRIES: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 191 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET
  • TABLE 195 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION
  • TABLE 196 NEAR-INFRARED IMAGING MARKET: REGION FOOTPRINT
  • TABLE 197 NEAR-INFRARED IMAGING MARKET: PRODUCT FOOTPRINT
  • TABLE 198 NEAR-INFRARED IMAGING MARKET: PROCEDURE FOOTPRINT
  • TABLE 199 NEAR-INFRARED IMAGING MARKET: APPLICATION FOOTPRINT
  • TABLE 200 NEAR-INFRARED IMAGING MARKET: END-USER FOOTPRINT
  • TABLE 201 NEAR-INFRARED IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 202 NEAR-INFRARED IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 203 NEAR-INFRARED IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 204 NEAR-INFRARED IMAGING MARKET: DEALS, JANUARY 2021-JULY 2025
  • TABLE 205 NEAR-INFRARED IMAGING MARKET: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 206 STRYKER: COMPANY OVERVIEW
  • TABLE 207 STRYKER: PRODUCTS OFFERED
  • TABLE 208 STRYKER: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 209 STRYKER: DEALS, JANUARY 2021-JULY 2025
  • TABLE 210 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW
  • TABLE 211 CARL ZEISS MEDITEC GROUP: PRODUCTS OFFERED
  • TABLE 212 CARL ZEISS MEDITEC GROUP: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 213 CARL ZEISS MEDITEC GROUP: DEALS, JANUARY 2021-JULY 2025
  • TABLE 214 CARL ZEISS MEDITEC GROUP: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 215 PERKINELMER, INC.: COMPANY OVERVIEW
  • TABLE 216 PERKINELMER, INC.: PRODUCTS OFFERED
  • TABLE 217 PERKINELMER, INC.: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 218 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 219 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 220 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 221 OLYMPUS CORPORATION: DEALS, JANUARY 2021-JULY 2025
  • TABLE 222 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 223 LEICA MICROSYSTEMS: COMPANY OVERVIEW
  • TABLE 224 LEICA MICROSYSTEMS: PRODUCTS OFFERED
  • TABLE 225 LEICA MICROSYSTEMS: DEALS, JANUARY 2021-JULY 2025
  • TABLE 226 LEICA MICROSYSTEMS: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 227 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
  • TABLE 228 KARL STORZ SE & CO. KG: PRODUCTS OFFERED
  • TABLE 229 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 230 SHIMADZU CORPORATION: PRODUCTS OFFERED
  • TABLE 231 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 232 SHIMADZU CORPORATION: DEALS, JANUARY 2021-JULY 2025
  • TABLE 233 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 234 LI-COR BIOTECH, LLC: COMPANY OVERVIEW
  • TABLE 235 LI-COR BIOTECH, LLC: PRODUCTS OFFERED
  • TABLE 236 LI-COR BIOTECH, LLC: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 237 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
  • TABLE 238 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED
  • TABLE 239 HAMAMATSU PHOTONICS K.K.: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 240 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW
  • TABLE 241 QUEST MEDICAL IMAGING B.V.: PRODUCTS OFFERED
  • TABLE 242 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 243 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 244 MERCK KGAA: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 245 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 246 MIZUHO MEDICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 247 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW
  • TABLE 248 TELEDYNE PRINCETON INSTRUMENTS: PRODUCTS OFFERED
  • TABLE 249 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 250 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 251 FLUOPTICS SAS: COMPANY OVERVIEW
  • TABLE 252 FLUOPTICS SAS: PRODUCTS OFFERED
  • TABLE 253 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 254 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 255 CAYMAN CHEMICAL: COMPANY OVERVIEW
  • TABLE 256 CAYMAN CHEMICAL: PRODUCTS OFFERED
  • TABLE 257 MP BIOMEDICALS: COMPANY OVERVIEW
  • TABLE 258 MP BIOMEDICALS: PRODUCTS OFFERED
  • TABLE 259 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW
  • TABLE 260 CRYSTA-LYN CHEMICAL COMPANY: PRODUCTS OFFERED
  • TABLE 261 GOWERLABS LTD.: COMPANY OVERVIEW
  • TABLE 262 GOWERLABS LTD.: PRODUCTS OFFERED
  • TABLE 263 NIRX MEDICAL TECHNOLOGIES, LLC: COMPANY OVERVIEW
  • TABLE 264 EXOSENS (XENICS NV): COMPANY OVERVIEW
  • TABLE 265 BIOTIUM: COMPANY OVERVIEW
  • TABLE 266 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.: COMPANY OVERVIEW
  • TABLE 267 AAT BIOQUEST, INC.: COMPANY OVERVIEW
  • TABLE 268 OXFORD INSTRUMENTS: COMPANY OVERVIEW
  • TABLE 269 MOTHERSON: COMPANY OVERVIEW
  • TABLE 270 PHOTON ETC: COMPANY OVERVIEW
  • TABLE 271 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 272 KERNEL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 NEAR-INFRARED IMAGING MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 NEAR-INFRARED IMAGING MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH
  • FIGURE 8 NEAR-INFRARED IMAGING MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET
  • FIGURE 15 RISING ADOPTION OF NEAR-INFRARED IMAGING IN SURGICAL AND DIAGNOSTIC APPLICATIONS DRIVING MARKET GROWTH
  • FIGURE 16 DEVICES SEGMENT HELD LARGEST SHARE OF MARKET IN 2O24
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 NORTH AMERICA TO CONTINUE TO DOMINATE NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD
  • FIGURE 19 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 NEAR-INFRARED IMAGING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 22 NEAR-INFRARED IMAGING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 NEAR-INFRARED IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEAR-INFRARED IMAGING PRODUCTS
  • FIGURE 25 KEY BUYING CRITERIA FOR NEAR-INFRARED IMAGING PRODUCTS
  • FIGURE 26 NEAR-INFRARED IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED IMAGING IN RECENT YEARS
  • FIGURE 27 NEAR-INFRARED IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED FLUORESCENCE IMAGING IN RECENT YEARS
  • FIGURE 28 NEAR-INFRARED DYES MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED FLUORESCENCE BIOLUMINESCENCE IMAGING IN RECENT YEARS
  • FIGURE 29 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY TYPE, 2024 (USD)
  • FIGURE 30 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 31 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION, 2024 (USD)
  • FIGURE 32 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 33 NEAR-INFRARED IMAGING MARKET: NUMBER OF DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 34 NEAR-INFRARED IMAGING MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 35 VALUE OF INVESTOR DEALS IN NEAR-INFRARED IMAGING MARKET, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 36 USE OF GEN AI IN NEAR-INFRARED IMAGING MARKET
  • FIGURE 37 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT
  • FIGURE 38 UK: NUMBER OF FLUOROSCOPY IMAGING ACTIVITIES (2023-2024)
  • FIGURE 39 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET (2020-2024)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET (2024)
  • FIGURE 42 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 43 NEAR-INFRARED IMAGING MARKET: COMPANY FOOTPRINT
  • FIGURE 44 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 NEAR-INFRARED IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 STRYKER: COMPANY SNAPSHOT (2024)
  • FIGURE 49 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2024)
  • FIGURE 50 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 52 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 53 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2024)
  • FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 55 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2024)
  • FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
目次
Product Code: MD 4138

The global near IR imaging market is projected to reach USD 1.99 billion by 2030 from USD 1.28 billion in 2025, at a CAGR of 9.3% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Procedure, Application, End User, and Region
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

The adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging, technological advancements in near-infrared imaging modalities, and the increasing number of surgical procedures globally are major factors anticipated to boost market growth in the forecasting years. Additionally, the advantages of near-infrared imaging over conventional visualization methods also pose as a factor that contributes enormously to the increase in demand for near-infrared imaging.

Near-infrared Imaging Market - IMG1

By procedure, the gastrointestinal surgeries segment accounted for the largest share of the market in 2024.

Based on procedure, the near-infrared imaging market is segmented into gastrointestinal surgeries, plastic/reconstructive surgeries, cancer surgeries, obstetrics & gynecology surgeries, cardiovascular surgeries, and other procedures. The gastrointestinal surgeries segment is further segmented into colorectal surgeries and other gastrointestinal surgeries. The rising incidence of gastrointestinal diseases such as colorectal cancer, Crohn's disease, ulcerative colitis, and gastric tumors significantly increases the need for surgical interventions, which is expected to fuel the demand for columns in the studied period.

By application, the clinical imaging segment accounted for the largest market share in 2024.

By application, the market is segmented into medical imaging, preclinical imaging, and clinical imaging. The clinical imaging segment accounted for the largest share of the market in 2024. The growth of this segment can be attributed to the increasing adoption of this imaging modality owing to the advantages offered by this technique and advancements in fluorescence imaging for clinical applications.

The Asia Pacific region is expected to register the highest growth rate during the forecast period.

By region, the near-infrared imaging market covers North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to register the highest growth rate during the forecast period. The presence of a large patient population, a rising geriatric population, and a huge population base for cancer and cardiovascular disease will fuel growth in this region during the forecast period.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1- 48%, Tier 2- 36%, and Tier 3- 16%
  • By Designation: Directors- 14%, C-level- 10%, and Others- 76%
  • By Region: North America- 40%, Europe- 32%, Asia Pacific- 20%, Latin America- 5%, Middle East & Africa- 3%

The prominent players in the near infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), LI-COR Biotech (US), Hamamatsu Photonics K.K. (Japan), Quest Medical Imaging B.V. (Netherlands), Merck KGaA (Germany), MIZUHO Corporation (Japan), Teledyne Princeton Instruments (US), Thermo Fisher Scientific Inc. (US), FLUOPTICS SAS (Getinge, France), Medtronic (Ireland), Cayman Chemical (US), MP Biomedicals (US), Crysta-LYN Chemical Company (US), and Gowerlabs Ltd. (UK), among others.

Research Coverage

This report studies the near-infrared imaging market based on product, procedure, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (Increasing number of surgical procedures globally, advantages of near-infrared imaging over conventional visualization methods, technological advancements in near-infrared imaging modalities, adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging), restraints (Lengthy approval process for near-infrared fluorophores, high initial capital and operational costs of near-infrared systems, availability of alternate technologies), opportunities (Growth potential in emerging economies, use of blockchain for distribution and storage of medical images), and challenges (Hospital budget cuts, dearth of trained professionals in emerging economies) influencing the growth of the near infrared imaging market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the near-infrared imaging market
  • Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the near-infrared imaging market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the near-infrared imaging market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA SOURCES
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of secondary sources
    • 2.1.2 PRIMARY DATA SOURCES
      • 2.1.2.1 List of key primary stakeholders interviewed
      • 2.1.2.2 Insights from primary experts
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
    • 2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
  • 2.3 MARKET FORECASTING
  • 2.4 PRIMARY RESEARCH VALIDATION
  • 2.5 DATA TRIANGULATION & MARKET BREAKDOWN
  • 2.6 RESEARCH ASSUMPTIONS
    • 2.6.1 STUDY ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW
  • 4.2 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT AND COUNTRY (2024)
  • 4.3 NEAR-INFRARED IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 NEAR-INFRARED IMAGING MARKET: REGIONAL MIX, 2023-2030 (USD MILLION)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing number of surgical procedures globally
      • 5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods
      • 5.2.1.3 Technological advancements in near-infrared imaging modalities
      • 5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lengthy approval process of near-infrared fluorophores
      • 5.2.2.2 High initial capital and operational costs of near-infrared systems
      • 5.2.2.3 Availability of alternate technologies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential for major players in emerging economies
      • 5.2.3.2 Use of blockchain for distribution and storage of medical images
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Hospital budget cuts
      • 5.2.4.2 Dearth of trained professionals in emerging economies
  • 5.3 REGULATORY ANALYSIS
    • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.3.2 REGULATORY LANDSCAPE
      • 5.3.2.1 North America
        • 5.3.2.1.1 US
        • 5.3.2.1.2 Canada
      • 5.3.2.2 Europe
      • 5.3.2.3 Asia Pacific
        • 5.3.2.3.1 Japan
        • 5.3.2.3.2 China
        • 5.3.2.3.3 India
      • 5.3.2.4 Middle East (GCC Region)
        • 5.3.2.4.1 UAE
        • 5.3.2.4.2 Saudi Arabia
      • 5.3.2.5 Africa
  • 5.4 REIMBURSEMENT ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
    • 5.5.1 RESEARCH & DEVELOPMENT
    • 5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT
    • 5.5.3 MARKETING, SALES, AND DISTRIBUTION
  • 5.6 SUPPLY CHAIN ANALYSIS
    • 5.6.1 PROMINENT COMPANIES
    • 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.6.3 END USERS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 THREAT OF NEW ENTRANTS
  • 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.9.2 KEY BUYING CRITERIA
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750)
    • 5.10.2 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750)
  • 5.11 PATENT ANALYSIS
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY TYPE
    • 5.12.2 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY KEY PLAYER
    • 5.12.3 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION
  • 5.13 TECHNOLOGY ANALYSIS
    • 5.13.1 KEY TECHNOLOGIES
      • 5.13.1.1 InGaAs (Indium Gallium Arsenide) detectors
      • 5.13.1.2 CMOS sensors
      • 5.13.1.3 Hyperspectral imaging
    • 5.13.2 COMPLEMENTARY TECHNOLOGIES
      • 5.13.2.1 Image processing software
      • 5.13.2.2 Optical coherence tomography (OCT)
      • 5.13.2.3 Raman spectroscopy
    • 5.13.3 ADJACENT TECHNOLOGIES
      • 5.13.3.1 SWIR (short-wave infrared) imaging
      • 5.13.3.2 Thermal imaging
      • 5.13.3.3 UV-VIS-NIR spectroscopy
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 TECHNOLOGICAL CHALLENGES
    • 5.14.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING
  • 5.15 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 UNMET NEEDS ANALYSIS
  • 5.19 IMPACT OF GENERATIVE AI ON NEAR-INFRARED IMAGING MARKET
  • 5.20 IMPACT OF 2025 US TARIFFS ON NEAR-INFRARED IMAGING MARKET
    • 5.20.1 KEY TARIFF RATES
    • 5.20.2 PRICE IMPACT ANALYSIS
    • 5.20.3 PRICE IMPACT ON COUNTRY/REGION
      • 5.20.3.1 US
      • 5.20.3.2 Europe
      • 5.20.3.3 Asia Pacific
    • 5.20.4 IMPACT ON COUNTRY/REGION
      • 5.20.4.1 US
      • 5.20.4.2 Europe
      • 5.20.4.3 Asia Pacific
    • 5.20.5 IMPACT ON END-USE INDUSTRIES

6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    • 6.2.1 FLUORESCENCE IMAGING SYSTEMS
      • 6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market
    • 6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS
      • 6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market
  • 6.3 AGENTS/PROBES
    • 6.3.1 INDOCYANINE GREEN
      • 6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segmental growth
    • 6.3.2 OTHER REAGENTS
  • 6.4 DYES
    • 6.4.1 ORGANIC DYES
      • 6.4.1.1 Unique molecular structure and better compatibility with biological systems to support market growth
    • 6.4.2 NANOPARTICLE DYES
      • 6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to boost adoption

7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE

  • 7.1 INTRODUCTION
  • 7.2 CANCER SURGERIES
    • 7.2.1 BRAIN CANCER/TUMOR SURGERIES
      • 7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market growth
    • 7.2.2 OTHER CANCER SURGERIES
  • 7.3 GASTROINTESTINAL SURGERIES
    • 7.3.1 COLORECTAL SURGERIES
      • 7.3.1.1 Advancements in treatment strategies and procedures to support market growth
    • 7.3.2 OTHER GASTROINTESTINAL SURGERIES
  • 7.4 CARDIOVASCULAR SURGERIES
    • 7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET GROWTH
  • 7.5 PLASTIC/RECONSTRUCTIVE SURGERIES
    • 7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO BOOST MARKET
  • 7.6 OBSTETRICS & GYNECOLOGY SURGERIES
    • 7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO CONTRIBUTE TO GROWTH
  • 7.7 OTHER PROCEDURES

8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 PRECLINICAL IMAGING
    • 8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET
  • 8.3 CLINICAL IMAGING
    • 8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO FUEL GROWTH
  • 8.4 MEDICAL IMAGING
    • 8.4.1 GROWING APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET

9 NEAR-INFRARED IMAGING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & SURGICAL CLINICS
    • 9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET GROWTH
  • 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO BOOST GROWTH
  • 9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
    • 9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH
  • 9.5 OTHER END USERS

10 NEAR-INFRARED IMAGING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Advanced healthcare infrastructure and favorable regulations to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Increased availability of research funding to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing healthcare expenditure and government spending to drive market growth
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to boost market
    • 10.3.4 UK
      • 10.3.4.1 Growing government initiatives and increasing incidence of chronic diseases to support growth
    • 10.3.5 ITALY
      • 10.3.5.1 Increased availability of reimbursement coverage for diagnostic procedures to fuel growth
    • 10.3.6 SPAIN
      • 10.3.6.1 Increasing prevalence of cancer and growing private-public funding to propel growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing healthcare reforms and government investments to drive market
    • 10.4.3 JAPAN
      • 10.4.3.1 Fast adoption of advanced technologies and growth in geriatric population to boost market
    • 10.4.4 INDIA
      • 10.4.4.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Growing healthcare spending and increasing investments in research to fuel growth
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Presence of advanced healthcare system and increased awareness about diseases to contribute to growth
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Greater purchasing power and more favorable demographic conditions to boost growth
    • 10.5.3 MEXICO
      • 10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Supportive government initiatives to aid market growth
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Procedure footprint
      • 11.5.5.5 Application footprint
      • 11.5.5.6 End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.6.5.1 Detailed list of key startups/SMEs
      • 11.6.5.2 Competitive benchmarking of key emerging players/startups
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 STRYKER
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 CARL ZEISS MEDITEC AG
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches
        • 12.1.2.3.2 Deals
        • 12.1.2.3.3 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 PERKINELMER, INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Expansions
    • 12.1.4 OLYMPUS CORPORATION
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches
        • 12.1.4.3.2 Deals
        • 12.1.4.3.3 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 LEICA MICROSYSTEMS
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
        • 12.1.5.3.2 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 KARL STORZ SE & CO. KG
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 MnM view
        • 12.1.6.3.1 Right to win
        • 12.1.6.3.2 Strategic choices
        • 12.1.6.3.3 Weaknesses & competitive threats
    • 12.1.7 SHIMADZU CORPORATION
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches
        • 12.1.7.3.2 Deals
        • 12.1.7.3.3 Expansions
    • 12.1.8 LI-COR BIOTECH, LLC
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product launches
    • 12.1.9 HAMAMATSU PHOTONICS K.K.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Expansions
    • 12.1.10 QUEST MEDICAL IMAGING B.V.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 MERCK KGAA (SIGMA-ALDRICH)
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Expansions
    • 12.1.12 MIZUHO MEDICAL CO., LTD.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 TELEDYNE PRINCETON INSTRUMENTS
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 THERMO FISHER SCIENTIFIC INC.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 FLUOPTICS SAS (PART OF GETINGE)
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
    • 12.1.16 MEDTRONIC
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products offered
    • 12.1.17 CAYMAN CHEMICAL
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products offered
    • 12.1.18 MP BIOMEDICALS
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products offered
    • 12.1.19 CRYSTA-LYN CHEMICAL COMPANY
      • 12.1.19.1 Business overview
      • 12.1.19.2 Products offered
    • 12.1.20 GOWERLABS LTD.
      • 12.1.20.1 Business overview
      • 12.1.20.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC
    • 12.2.2 EXOSENS (XENICS NV)
    • 12.2.3 BIOTIUM
    • 12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.
    • 12.2.5 AAT BIOQUEST, INC.
    • 12.2.6 OXFORD INSTRUMENTS
    • 12.2.7 MOTHERSON
    • 12.2.8 PHOTON ETC
    • 12.2.9 SOTERIX MEDICAL INC.
    • 12.2.10 KERNEL

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS